questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Signes et symptômes digestifs
Hyperphagie
Hyperphagie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hyperphagie
Troubles de l'alimentation
Évaluation psychologique
Nutrition
Trouble de l'hyperphagie boulimique
DSM-5
Symptômes
5
Symptômes
Troubles de l'alimentation
Douleur abdominale
Hyperphagie
Diabète de type 2
Troubles métaboliques
Prévention
5
Éducation nutritionnelle
Gestion du stress
Soutien social
Troubles alimentaires
Sensibilisation
Prévention
Exercice physique
Comportements alimentaires
Méditation
Gestion du stress
Traitements
5
Thérapie comportementale
Médicaments
Thérapie cognitive
Comportement alimentaire
Soutien nutritionnel
Habitudes alimentaires
Hospitalisation
Traitement intensif
Complications
5
Maladies cardiovasculaires
Obésité
Reflux gastro-œsophagien
Douleurs abdominales
Troubles du sommeil
Inconfort physique
Facteurs de risque
5
Antécédents familiaux
Stress
Stress
Troubles alimentaires
Antécédents de troubles alimentaires
Hyperphagie
Isolement social
Comportements alimentaires
Changements hormonaux
Appétit
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperphagie : Questions médicales les plus fréquentes",
"headline": "Hyperphagie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperphagie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperphagie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Signes et symptômes digestifs",
"url": "https://questionsmedicales.fr/mesh/D012817",
"about": {
"@type": "MedicalCondition",
"name": "Signes et symptômes digestifs",
"code": {
"@type": "MedicalCode",
"code": "D012817",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Boulimie",
"alternateName": "Bulimia",
"url": "https://questionsmedicales.fr/mesh/D002032",
"about": {
"@type": "MedicalCondition",
"name": "Boulimie",
"code": {
"@type": "MedicalCode",
"code": "D002032",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.645.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperphagie",
"alternateName": "Hyperphagia",
"code": {
"@type": "MedicalCode",
"code": "D006963",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andrea M Haqq",
"url": "https://questionsmedicales.fr/author/Andrea%20M%20Haqq",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, University of Alberta, 8440 - 112 St NW, Edmonton, AB, T6G 2B7, Canada. haqq@ualberta.ca."
}
},
{
"@type": "Person",
"name": "Arashdeep Singh",
"url": "https://questionsmedicales.fr/author/Arashdeep%20Singh",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA."
}
},
{
"@type": "Person",
"name": "Julia von Schnurbein",
"url": "https://questionsmedicales.fr/author/Julia%20von%20Schnurbein",
"affiliation": {
"@type": "Organization",
"name": "Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany."
}
},
{
"@type": "Person",
"name": "Martin Wabitsch",
"url": "https://questionsmedicales.fr/author/Martin%20Wabitsch",
"affiliation": {
"@type": "Organization",
"name": "Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany. Electronic address: Martin.Wabitsch@uniklinik-ulm.de."
}
},
{
"@type": "Person",
"name": "Usha G Mallya",
"url": "https://questionsmedicales.fr/author/Usha%20G%20Mallya",
"affiliation": {
"@type": "Organization",
"name": "Rhythm Pharmaceuticals, Inc., Boston, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Interaction of buspirone and its major metabolites with human organic cation transporters.",
"datePublished": "2023-03-02",
"url": "https://questionsmedicales.fr/article/36843181",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/fcp.12883"
}
},
{
"@type": "ScholarlyArticle",
"name": "Usefulness of Therapeutic Drug Monitoring and Pharmacogenetics for a Patient Treated with Olanzapine, Buspirone, and Fluvoxamine: A Case Study.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36917730",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/FTD.0000000000001093"
}
},
{
"@type": "ScholarlyArticle",
"name": "Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST).",
"datePublished": "2023-04-13",
"url": "https://questionsmedicales.fr/article/37052334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/apt.17479"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications.",
"datePublished": "2022-07-16",
"url": "https://questionsmedicales.fr/article/35840767",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00737-022-01250-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Buspirone in Autism Spectrum Disorder: A Systematic Review.",
"datePublished": "2023-05-21",
"url": "https://questionsmedicales.fr/article/37378184",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.39304"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Signes et symptômes digestifs",
"item": "https://questionsmedicales.fr/mesh/D012817"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hyperphagie",
"item": "https://questionsmedicales.fr/mesh/D006963"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperphagie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperphagie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperphagie",
"description": "Comment diagnostiquer l'hyperphagie ?\nQuels tests sont utilisés pour l'hyperphagie ?\nL'hyperphagie est-elle liée à d'autres troubles ?\nQuels critères DSM sont utilisés pour l'hyperphagie ?\nL'hyperphagie peut-elle être confondue avec d'autres troubles ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Buspirone#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperphagie",
"description": "Quels sont les symptômes de l'hyperphagie ?\nL'hyperphagie provoque-t-elle des douleurs ?\nY a-t-il des signes psychologiques associés ?\nComment l'hyperphagie affecte-t-elle le poids ?\nL'hyperphagie peut-elle causer des troubles métaboliques ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Buspirone#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperphagie",
"description": "Comment prévenir l'hyperphagie ?\nLe soutien social aide-t-il à prévenir l'hyperphagie ?\nLes programmes de sensibilisation sont-ils efficaces ?\nL'exercice physique aide-t-il à prévenir l'hyperphagie ?\nLes techniques de relaxation sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Buspirone#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperphagie",
"description": "Quels traitements sont disponibles pour l'hyperphagie ?\nLa thérapie cognitive est-elle efficace ?\nDes médicaments sont-ils prescrits pour l'hyperphagie ?\nLe soutien nutritionnel est-il important ?\nL'hyperphagie nécessite-t-elle une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Buspirone#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperphagie",
"description": "Quelles complications peuvent survenir avec l'hyperphagie ?\nL'hyperphagie peut-elle affecter la santé mentale ?\nY a-t-il des risques de maladies cardiovasculaires ?\nDes problèmes digestifs peuvent-ils survenir ?\nL'hyperphagie peut-elle entraîner des troubles du sommeil ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Buspirone#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperphagie",
"description": "Quels sont les facteurs de risque de l'hyperphagie ?\nLe stress est-il un facteur de risque ?\nLes antécédents de troubles alimentaires augmentent-ils le risque ?\nL'isolement social est-il un facteur de risque ?\nLes changements hormonaux influencent-ils l'hyperphagie ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Buspirone#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperphagie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des habitudes alimentaires et des symptômes associés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'hyperphagie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun test spécifique, mais des évaluations psychologiques et nutritionnelles peuvent être effectuées."
}
},
{
"@type": "Question",
"name": "L'hyperphagie est-elle liée à d'autres troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut coexister avec des troubles comme l'anxiété ou la dépression."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont utilisés pour l'hyperphagie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le DSM-5 définit des critères spécifiques pour le trouble de l'hyperphagie boulimique."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle être confondue avec d'autres troubles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la boulimie ou l'orthorexie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hyperphagie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une consommation excessive de nourriture, des sentiments de honte et de culpabilité."
}
},
{
"@type": "Question",
"name": "L'hyperphagie provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des douleurs abdominales dues à une suralimentation fréquente."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes psychologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes comme l'anxiété, la dépression et une faible estime de soi sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment l'hyperphagie affecte-t-elle le poids ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une prise de poids significative et des problèmes de santé associés."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle causer des troubles métaboliques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut contribuer à des troubles métaboliques comme le diabète de type 2."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperphagie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une éducation nutritionnelle et la gestion du stress."
}
},
{
"@type": "Question",
"name": "Le soutien social aide-t-il à prévenir l'hyperphagie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soutien social peut réduire le risque de développer des troubles alimentaires."
}
},
{
"@type": "Question",
"name": "Les programmes de sensibilisation sont-ils efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes de sensibilisation peuvent aider à identifier et à traiter les problèmes tôt."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir l'hyperphagie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer l'humeur et réduire les comportements alimentaires compulsifs."
}
},
{
"@type": "Question",
"name": "Les techniques de relaxation sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la méditation peuvent aider à gérer le stress et les envies alimentaires."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'hyperphagie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale, la médication et le soutien nutritionnel."
}
},
{
"@type": "Question",
"name": "La thérapie cognitive est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie cognitive peut aider à modifier les comportements alimentaires et les pensées."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils prescrits pour l'hyperphagie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antidépresseurs et des médicaments anti-anxiété peuvent être prescrits pour aider."
}
},
{
"@type": "Question",
"name": "Le soutien nutritionnel est-il important ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un soutien nutritionnel aide à établir des habitudes alimentaires saines."
}
},
{
"@type": "Question",
"name": "L'hyperphagie nécessite-t-elle une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, une hospitalisation peut être nécessaire pour un traitement intensif."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hyperphagie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'obésité, le diabète, et des problèmes cardiovasculaires."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle affecter la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des troubles mentaux comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies cardiovasculaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperphagie augmente le risque de maladies cardiovasculaires en raison de l'obésité."
}
},
{
"@type": "Question",
"name": "Des problèmes digestifs peuvent-ils survenir ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes comme le reflux gastro-œsophagien et des douleurs abdominales peuvent se produire."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle entraîner des troubles du sommeil ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des troubles du sommeil en raison de l'inconfort physique et psychologique."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hyperphagie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des troubles mentaux et des événements stressants."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel peut déclencher des épisodes d'hyperphagie chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Les antécédents de troubles alimentaires augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de troubles alimentaires augmente le risque d'hyperphagie."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement social peut contribuer à des comportements alimentaires désordonnés."
}
},
{
"@type": "Question",
"name": "Les changements hormonaux influencent-ils l'hyperphagie ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements hormonaux, comme ceux liés à la grossesse, peuvent affecter l'appétit."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Pediatrics, University of Alberta, 8440 - 112 St NW, Edmonton, AB, T6G 2B7, Canada. haqq@ualberta.ca.
Publications dans "Hyperphagie" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany. Electronic address: Martin.Wabitsch@uniklinik-ulm.de.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Rhythm Pharmaceuticals, Inc., Boston, MA, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Hypothalamic Research, Departments of Internal Medicine and Neuroscience, Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Hypothalamic Research, Departments of Internal Medicine and Neuroscience, Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Vanderbilt University Medical Center, Nashville, Tennessee.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Case Western Reserve University, Cleveland, Ohio.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
The John B. Pierce Laboratory, New Haven, CT, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA; The John B. Pierce Laboratory, New Haven, CT, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA; The John B. Pierce Laboratory, New Haven, CT, USA; Yale University, New Haven, CT, USA. Electronic address: gdelartigue@ufl.edu.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics University of Florida College of Medicine Gainesville Florida USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Foundation for Prader-Willi Research, Walnut, California, United States of America.
PWS-Clinical Trial Consortium, Walnut, California, United States of America.
Department of Genetics, University of Alabama, Birmingham, Alabama, United States of America.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Foundation for Prader-Willi Research, Walnut, California, United States of America.
PWS-Clinical Trial Consortium, Walnut, California, United States of America.
Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, United States of America.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Sağlik Bilimleri University, Tepecik Training and Research Hospital, İzmir, Turkey.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Nutrition and Dietetics, Sağlik Bilimleri University, Tepecik Training and Research Hospital, İzmir, Turkey.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Dokuz Eylül University, Faculty of Medicine, İzmir, Turkey.
Publications dans "Hyperphagie" :
Buspirone, a cationic drug, is an anxiolytic and antidepressant drug. However, whether buspirone and its metabolites are interacted with organic cationic transporter remains uncertain. In this study, ...
A patient, with a mental disorder caused by an intracranial infection, treated with olanzapine, fluvoxamine, and buspirone. The plasma exposure of olanzapine was too high at standard doses, with evide...
Using pharmacogenomics and therapeutic drug monitoring to guide drug dose adjustment for a patient in clinical practice....
The patient underwent pharmacogenetic testing in addition to therapeutic drug monitoring as part of a pharmacist-led comprehensive evaluation of medication therapy management in a clinical setting, re...
This case study demonstrates that therapeutic drug monitoring combined with pharmacogenetic-guided dose adjustment can aid in the management of patients receiving complex pharmacological treatments....
Patients with gastroparesis and related disorders have symptoms including early satiety, postprandial fullness and bloating. Buspirone, a 5-HT...
To determine if buspirone treatment improves early satiety and postprandial fullness in patients with symptoms of gastroparesis....
This 4-week multi-centre clinical trial randomised patients with symptoms of gastroparesis and moderate-to-severe symptoms of fullness (Gastroparesis Cardinal Symptom Index [GCSI] early satiety/postpr...
Ninety-six patients (47 buspirone, 49 placeboes; 92% female, 50% delayed gastric emptying, 39% diabetic) were enrolled. There was no between-groups difference in the 4-week ES/PPF primary outcome: -1....
Patients with moderate-to-severe early satiety/postprandial fullness and other symptoms of gastroparesis did not benefit from buspirone treatment to improve the ES/PPF primary outcome compared with pl...
ClinicalTrials.gov NCT0358714285....
Buspirone is commonly used to treat anxiety disorders among reproductive-aged women. To date, the reproductive safety of buspirone in humans has been particularly sparse. We sought to provide prelimin...
The aim of this systematic review is to appraise the current evidence on the efficacy and safety of buspirone in core symptoms of autism spectrum disorder (ASD), co-occurring anxiety, and other associ...
Patho-physiological changes in liver cirrhosis create portacaval shunts that allow blood flow to bypass the hepatic portal vein into the systemic circulation affecting drug pharmacokinetics (PKs). The...
Jails in the United States are required to provide health care to the over 10 million people entering jails each year, a significant portion of whom need medications. Yet little is known about the pro...
To describe medication access, policy, and procedures in jails....
Semi-structured interviews were conducted with administrators and health workers from 34 jails (of 125 contacted) across 5 states in the southeastern United States. The interview guide covered all asp...
Four processes described medication use chronologically from intake to release: jail entry and health screening, pharmacy and medication protocols, protocols specific to medication dispensing and admi...
Medication access, protocols, and procedures in jails varies considerably, and there is a need for further adoption of existing standards and guidelines for the use of medications in jails, such as th...
In addition to their well-known anxiolytic functions, benzodiazepines produce hyperphagia. Previously, we reported that the benzodiazepine, chlordiazepoxide (CDP), increased consumption of both normal...
The term central sleep apnoea (CSA) encompasses diverse clinical situations where a dysfunctional drive to breathe leads to recurrent respiratory events, namely apnoea (complete absence of ventilation...
To evaluate the benefits and harms of pharmacological treatment compared with active or inactive controls for central sleep apnoea in adults....
We used standard, extensive Cochrane search methods. The latest search date was 30 August 2022....
We included parallel and cross-over randomised controlled trials (RCTs) that evaluated any type of pharmacological agent compared with active controls (e.g. other medications) or passive controls (e.g...
We used standard Cochrane methods. Our primary outcomes were central apnoea-hypopnoea index (cAHI), cardiovascular mortality and serious adverse events. Our secondary outcomes were quality of sleep, q...
We included four cross-over RCTs and one parallel RCT, involving a total of 68 participants. Mean age ranged from 66 to 71.3 years and most participants were men. Four trials recruited people with CSA...
There is insufficient evidence to support the use of pharmacological therapy in the treatment of CSA. Although small studies have reported positive effects of certain agents for CSA associated with he...
Preclinical evidence suggests that co-administration of the 5-HT...
Assess the therapeutic potential of a fixed-dose buspirone and zolmitriptan combination in Parkinson's disease (PD) patients with levodopa-induced dyskinesia....
Single-center, randomized, placebo-controlled, two-way crossover study (NCT02439203) of a fixed-dose buspirone/zolmitriptan regimen (10/1.25 mg three times a day) in 30 patients with PD experiencing a...
Seven days of treatment with buspirone/zolmitriptan added to levodopa significantly reduced dyskinesia as assessed by Abnormal Involuntary Movement Scale scores versus placebo (mean treatment effect v...
In this proof-of-concept study, addition of buspirone/zolmitriptan to the patients' PD medication regimen significantly reduced dyskinesia severity without worsening motor function. © 2024 Internation...